Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 143074, 12 pages
http://dx.doi.org/10.1155/2015/143074
Research Article

3,5,4′-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway

1Department of Respiration, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, China
2School of Accounting, Xijing University, Xi’an 710032, China
3Department of Medicinal Chemistry, School of Pharmacy, Fourth Military Medical University, Xi’an 710032, China

Received 5 July 2015; Revised 12 October 2015; Accepted 22 October 2015

Academic Editor: Kang-Yun Lee

Copyright © 2015 Lijie Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Koh, “Update in acute respiratory distress syndrome,” Journal of Intensive Care, vol. 2, article 2, 2014. View at Publisher · View at Google Scholar
  2. J. Villar, J. Blanco, J. M. Añón et al., “The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation,” Intensive Care Medicine, vol. 37, no. 12, pp. 1932–1941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Mafra de Lima, K. T. Naves, A. H. Machado, R. Albertini, A. B. Villaverde, and F. Aimbire, “Lung inflammation and endothelial cell damage are decreased after treatment with phototherapy (PhT) in a model of acute lung injury induced by Escherichia coli lipopolysaccharide in the rat,” Cell Biology International, vol. 33, no. 12, pp. 1212–1221, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Jing, M. Chunhua, and W. Shumin, “Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-kappaB pathway in vivo and in vitro,” Toxicology and Applied Pharmacology, vol. 285, no. 2, pp. 128–135, 2015. View at Publisher · View at Google Scholar
  5. D. G. Geboers, F. M. de Beer, A. M. Boer et al., “Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients,” Intensive Care Medicine, vol. 41, no. 7, pp. 1281–1290, 2015. View at Publisher · View at Google Scholar
  6. S. Khan, R. J. Choi, O. Shehzad et al., “Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling in in vitro and in vivo experimental models,” Journal of Ethnopharmacology, vol. 145, no. 2, pp. 626–637, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Bhaskaran, S. Shukla, J. K. Srivastava, and S. Gupta, “Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity,” International Journal of Molecular Medicine, vol. 26, no. 6, pp. 935–940, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Hayden and S. Ghosh, “NF- kappaB in immunobiology,” Cell Research, vol. 21, no. 2, pp. 223–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-C. Chi, S.-P. Lin, and Y.-C. Hou, “A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats,” Toxicology and Applied Pharmacology, vol. 263, no. 3, pp. 315–322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. K. Vella, C. Pullen, F. R. Coulson, and A. S. Fenning, “Resveratrol prevents cardiovascular complications in the SHR/STZ rat by reductions in oxidative stress and inflammation,” BioMed Research International, vol. 2015, Article ID 918123, 8 pages, 2015. View at Publisher · View at Google Scholar
  11. Q. Xu and L.-Y. Si, “Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action,” Nutrition Research, vol. 32, no. 9, pp. 648–658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Liu, H. Liang, Q. Xia et al., “Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression,” Clinical and Translational Oncology, vol. 15, no. 9, pp. 741–746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-Q. Xue, J.-M. Di, Y. Luo, K.-J. Cheng, X. Wei, and Z. Shi, “Resveratrol oligomers for the prevention and treatment of cancers,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 765832, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Poulsen, K. Fjeldborg, M. J. Ornstrup, T. N. Kjær, M. K. Nøhr, and S. B. Pedersen, “Resveratrol and inflammation: challenges in translating pre-clinical findings to improved patient outcomes,” Biochimica et Biophysica Acta, vol. 1852, no. 6, pp. 1124–1136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Liu, C. Jiang, J. Zhang, B. Liu, and Q. Du, “Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities,” Journal of Diabetes, 2015. View at Publisher · View at Google Scholar
  16. T. Finkel, C.-X. Deng, and R. Mostoslavsky, “Recent progress in the biology and physiology of sirtuins,” Nature, vol. 460, no. 7255, pp. 587–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Walle, F. Hsieh, M. H. DeLegge, J. E. Oatis Jr., and U. K. Walle, “High absorption but very low bioavailability of oral resveratrol in humans,” Drug Metabolism and Disposition, vol. 32, no. 12, pp. 1377–1382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Dobrydneva, R. L. Williams, G. Z. Morris, and P. F. Blackmore, “Dietary phytoestrogens and their synthetic structural analogues as calcium channel blockers in human platelets,” Journal of Cardiovascular Pharmacology, vol. 40, no. 3, pp. 399–410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Liang, X. Liu, Q. Wang, S. Cheng, S. Zhang, and M. Zhang, “Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4′-tri-O-acetylresveratrol in rats,” Phytomedicine, vol. 20, no. 6, pp. 558–563, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Ma, Y. Li, Y. Zhao et al., “3,5,4′-Tri-O-acetylresveratrol ameliorates seawater exposure-induced lung injury by upregulating connexin 43 expression in lung,” Mediators of Inflammation, vol. 2013, Article ID 182132, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Koide, S. Osman, A. L. Garner et al., “The use of 3,5,4′-tri-O-acetylresveratrol as a potential prodrug for resveratrol protects mice from γ-irradiation-induced death,” ACS Medicinal Chemistry Letters, vol. 2, no. 4, pp. 270–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Zhang, Z.-Y. Liu, Y.-Y. Li et al., “Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice,” European Journal of Pharmaceutical Sciences, vol. 44, no. 5, pp. 573–579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. R. Janz and L. B. Ware, “Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials,” Seminars in Respiratory and Critical Care Medicine, vol. 34, no. 4, pp. 537–548, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. L. B. Ware, “Autopsy in ARDS: insights into natural history,” The Lancet Respiratory Medicine, vol. 1, no. 5, pp. 352–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. L. W. Soromou, N. Chen, L. Jiang et al., “Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-kappaB signaling pathway,” Biochemical and Biophysical Research Communications, vol. 419, no. 2, pp. 256–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Herold, N. M. Gabrielli, and I. Vadász, “Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 305, no. 10, pp. L665–L681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Zhu, D.-X. Wang, W. Zhang et al., “Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB,” PLoS ONE, vol. 8, no. 2, Article ID e56407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. D. El Kebir, L. József, W. Pan, and J. G. Filep, “Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation,” Circulation Research, vol. 103, no. 4, pp. 352–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. K. Cribbs and G. S. Martin, “Stem cells in sepsis and acute lung injury,” The American Journal of the Medical Sciences, vol. 341, no. 4, pp. 325–332, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Müller, S. Beissert, and D. Kulms, “Anti-apoptotic NF-κB and ‘gain of function’ mutp53 in concert act pro-apoptotic in response to UVB+IL-1 via enhanced TNF production,” Journal of Investigative Dermatology, vol. 135, no. 3, pp. 851–860, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Bianchi, I. Giambanco, and R. Donato, “S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha,” Neurobiology of Aging, vol. 31, no. 4, pp. 665–677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. X. Jian, M. Z. Li, W. Y. Zheng et al., “Tormentic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts via inhibition of TLR4-mediated NF-κB and MAPK signalling pathway,” Archives of Oral Biology, vol. 60, no. 9, pp. 1327–1332, 2015. View at Publisher · View at Google Scholar
  33. J. Yamana, L. Santos, and E. Morand, “Enhanced induction of LPS-induced fibroblast MCP-1 by interferon-γ: involvement of JNK and MAPK phosphatase-1,” Cellular Immunology, vol. 255, no. 1-2, pp. 26–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. N. W. Lucchi and J. M. Moore, “LPS induces secretion of chemokines by human syncytiotrophoblast cells in a MAPK-dependent manner,” Journal of Reproductive Immunology, vol. 73, no. 1, pp. 20–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Cetrullo, S. D’Adamo, B. Tantini, R. M. Borzi, and F. Flamigni, “mTOR, AMPK, and Sirt1: key players in metabolic stress management,” Critical Reviews in Eukaryotic Gene Expression, vol. 25, no. 1, pp. 59–75, 2015. View at Publisher · View at Google Scholar
  36. C. Ehlting, O. Böhmer, M. J. Hahnel et al., “Oncostatin M regulates SOCS3 mRNA stability via the MEK–ERK1/2-pathway independent of p38MAPK/MK2,” Cellular Signalling, vol. 27, no. 3, pp. 555–567, 2015. View at Publisher · View at Google Scholar
  37. A. D. Napper, J. Hixon, T. McDonagh et al., “Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1,” Journal of Medicinal Chemistry, vol. 48, no. 25, pp. 8045–8054, 2005. View at Publisher · View at Google Scholar · View at Scopus